- Home
- NURO
NURO
NeuroMetrix Inc.
as 04-23-2025 4:00pm EST
| Founded: | 1996 | Country: | United States |
| Employees: | N/A | City: | WALTHAM |
| Market Cap: | N/A | IPO Year: | N/A |
| Target Price: | N/A | AVG Volume (30 days): | 2.7K |
| Analyst Decision: | N/A | Number of Analysts: | N/A |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -3.96 | EPS Growth: | N/A |
| 52 Week Low/High: | $2.66 - $4.73 | Next Earning Date: | 05-14-2025 |
| Revenue: | $3,032,837 | Revenue Growth: | -48.61% |
| Revenue Growth (this year): | N/A | Revenue Growth (next year): | N/A |
Latest NeuroMetrix Inc. News
NURO Breaking Stock News: Dive into NURO Ticker-Specific Updates for Smart Investing
Insider Monkey
4 months ago
Here’s Why NeuroMetrix, Inc. (NASDAQ:NURO) Is Among the Best Diabetes Stocks to Buy Under $10
MT Newswires
4 months ago
electroCore to Acquire NeuroMetrix to Become Diversified Player in Non-Invasive Wellness Treatments
GlobeNewswire
4 months ago
NeuroMetrix to be Acquired by electroCore
Zacks
6 months ago
NeuroMetrix Q3 Loss Narrows Y/Y, Quell Sales Drives Growth
Simply Wall St.
6 months ago
NeuroMetrix Third Quarter 2024 Earnings: US$0.75 loss per share (vs US$1.66 loss in 3Q 2023)
GlobeNewswire
6 months ago
NeuroMetrix Reports Q3 2024 Business Highlights
MT Newswires
8 months ago
NeuroMetrix Finds No Viable Transactions in Strategic Review
GlobeNewswire
8 months ago
NeuroMetrix Reiterates its Review of Strategic Alternatives
Compare NURO vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "NURO NeuroMetrix Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.